FHA
TAK icon

Flagship Harbor Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Flagship Harbor Advisors’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-509
Closed -$9K – 1622
2020
Q3 		$9K Sell
509
-354
-41% -$6.45K ﹤0.01% 1370
2020
Q2 		$15K Buy
863
+265
+44% +$4.76K ﹤0.01% 1237
2020
Q1 		$9K Buy
598
+150
+33% +$2.72K ﹤0.01% 1277
2019
Q4 		$9K Buy
448
+6
+1% +$115 ﹤0.01% 1379
2019
Q3 		$7K Sell
442
-94
-18% -$1.63K ﹤0.01% 1404
2019
Q2 		$9K Buy
536
+46
+9% +$837 ﹤0.01% 1341
2019
Q1 		$10K Buy
+490
New +$9.86K ﹤0.01% 1304

Other funds holding TAK

GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM